FDA approves first-ever RSV vaccine, shots to be available for older adults

FDA approves first-ever RSV vaccine, shots to be available for older adults

Upworthy

Published

The Food and Drug Administration approved Wednesday the first-ever vaccine to combat severe respiratory syncytial virus, or RSV. Arexvy, the new vaccine developed by GlaxoSmithKline, was approved for adults 60 and older and was 82% effective at preventing lower respiratory tract illness caused by…

#rsv #arexvy #fda #petermarks #gsk #gbs #cdc #nonesanofis #sanofi #astrazeneca

Full Article